(1)H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug

por Vermathen, Martina, Paul, Lydia E. H., Diserens, Gaëlle, Vermathen, Peter, Furrer, Julien
Publicado 2015

(1)H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC(6)H(4)(i)Pr)(2)Ru(2)(SC(6)H(4)-p-Bu(t))(3)](+) (DiRu-1)

por Primasová, Hedvika, Paul, Lydia E. H., Diserens, Gaëlle, Primasová, Ester, Vermathen, Peter, Vermathen, Martina, Furrer, Julien
Publicado 2019